UDC: 338.1
https://doi.org/10.25198/2077-7175-2024-5-11
EDN: JPNDKW


viewing

THE INTRODUCTION OF DIGITAL TWINS INTO THE PRODUCTION CYCLES OF BIOTECH COMPANIES IN THE CONTEXT OF THE PHARMA 4.0 CONCEPT

L. V. Lapidus1, A. A. Kravchenko2
Lomonosov Moscow State University, Moscow, Russia
1e-mail: infodilemma@yandex.ru
2e-mail: kravchenko.anastasia35@gmail.com

Abstract. Digital transformation allows you to achieve a competitive advantage in the market while reducing costs and expenses, but at the same time improving quality, which is a cornerstone aspect in the biotechnology industry. The pharmaceutical market is steadily growing, this is especially evident after the COVID-19 pandemic, which contributed to the emergence of a large number of drugs produced using digital twins. Doppelgangers are beginning to play an increasingly important role in biotechnological production, which has a positive effect on increasing company revenue, reducing costs, and improving production safety.

The purpose of this study is to analyze the current state of the biotechnology market, assess the prospects for the introduction of digital twins into production cycles, as well as identify key areas and trends in the biotechnology industry.

The article examines the cases of already successfully functioning digital counterparts, provides an analysis of the current state of the market and a forecast for its growth in the coming years. Special attention is paid to the new Pharma 4.0 concept and the effects that are designed to completely transform the industry with the help of digital technologies, the locomotive of which is the digital twin.

During the research, the authors relied on the scientific works of domestic and foreign scientists from Germany, China, the Netherlands, the Russian Federation, the USA, and South Korea. The information base was compiled by reports from big pharma companies, vendors of digital twin solutions, consulting companies: McKinsey, PwC, Pfizer, Merck, GlaxoSmithKline, Siemens, Aveva, Philips, AstraZeneca, statistical data Market.US , Yahoo.Finance, ISPE.

Key words: digital twin, digitalization, process modeling, Industry 4.0., Pharma 4.0., biotechnological production, process modeling, digital modeling, pharmaceutical production.

Cite as: Lapidus, L. V., Kravchenko, A. A. (2024) [The introduction of digital twins into the production cycles of biotech companies in the context of the Pharma 4.0 concept]. Intellekt. Innovacii. Investicii [Intellect. Innovations. Investments]. Vol. 5, pp. 11–25. – https://doi.org/10.25198/2077-7175-2024-5-11.


References

  1. Borovkov, A. I., Ryabov, Yu. A., Gamzikova, A. A. (2020) [Digital twins in oil and gas engineering]. Delovoy zhurnal Neftegaz.Ru [Business magazine Neftegaz.Ru]. Vol. 6 (102), pp. 30–36. – EDN: IAQWUQ. (In Russ.).
  2. Borovkov, A. I., Ryabov, Yu. A. (2019) [Definition, development and application of digital twins: the approach of the NTI Competence Center of SPbPU «New production technologies»]. Tsifrovaya podstantsiya [Digital substation]. Vol. 12, pp. 20–25. (In Russ.).
  3. Kosheleva, O. E., Pavlova, A. O. (2022) [The role of Russia’s intellectual resources in expanding the scope of digital twins and accelerating digital progress]. Byulleten’ innovatsionnykh tekhnologiy [Bulletin of innovative technologies]. Vol. 6, No. 4(24), pp. 29–33. – EDN: RPXNIB. (In Russ.).
  4. Prokhorov, A., Lysachev, M. (2020) Tsifrovoy dvoynik. Analiz, trendy, mirovoy opyt. Izdaniye pervoye, ispravlennoye i dopolnennoye [Digital twin. Analysis, trends, world experience. First edition, revised and supplemented]. Scientific editor Professor Borovkov A. M .: OOO AlliancePrint, 401 p.
  5. Baillargeon, B., et al. (2014) The Living Heart Project: A robust and integrative simulator for human heart function. Eur. J. Mech. A-Solids, Vol. 48, pp. 38–47. – https://doi.org/10.1016/j.euromechsol.2014.04.001. (In Eng.).
  6. Bao, J., et al. (2018) The modelling and operations for the digital twin in the context of manufacturing. Enterp. Inf. Syst., Vol. 13, No. 4, pp. 534–556. – https://doi.org/10.1080/17517575.2018.1526324. (In Eng.).
  7. Branke, J., Farid, S., Shah, N. (2016) Industry 4.0: a vision for personalized medicine supply chains? Cell Gene Ther. Insights Vol. 2, No. 2, pp. 263–270. (In Eng.).
  8. Bruynseels, K., de Sio F. S., van den Hoven J. (2018) Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm. Front. Genet., Vol. 9, p. 31. (In Eng.).
  9. Cheng, Y., et al. (2018) Cyber-physical integration for moving digital factories forward towards smart manufacturing: A survey. Int. J. Adv. Manuf. Technol., Vol. 97, pp. 1209–1221. – https://doi.org/10.1007/s00170-018-2001-2. (In Eng.).
  10. Damiani, L., et al. (2018) Augmented and virtual reality applications in industrial systems: A qualitative review towards the industry 4.0 era. IFAC-PapersOnLine, Vol. 51, No. 11, pp. 624–630. – https://doi.org/10.1016/j.ifacol.2018.08.388. (In Eng.).
  11. Damjanovic-Behrendt, V. (2018) A digital twin-based privacy enhancement mechanism for the automotive industry. In Proceedings of the 2018 International Conference on Intelligent Systems (IS), Funchal-Madeira, Portugal, 25–27 September 2018. – https://doi.org/10.1109/IS.2018.8710526. (In Eng.).
  12. De Man, J. C., Strandhagen, J. O. (2017) An industry 4.0 research agenda for sustainable business models. Procedia CIRP. Vol. 63, pp.721–726. (In Eng.).
  13. Ding, B. (2018) Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf. Environ. Prot. Vol. 119, pp. 115–130. (In Eng.).
  14. Gernaey, Krist V., Cervera-Padrell, Albert E., Woodley, John M. (2012) A perspective on PSE in pharmaceutical process development and innovation. Computers & Chemical Engineering. Vol. 42. No. 2, pp. 15–29. – https://doi.org/10.1016/j.compchemeng.2012.02.022. (In Eng.).
  15. Grieves, M. (2016) Origins of the Digital Twin Concept. – https://doi.org/10.13140/RG.2.2.26367.61609. (In Eng.).
  16. Herwig, C., Wölbeling C., Zimmer T. (2017) A Holistic Approach to Production Control From Industry 4.0 to Pharma 4.0. Vol. 37. No. 3, pp. 44–49. (In Eng.).
  17. Jones, D., et al. (2020) Characterising the Digital Twin: A systematic literature review. CIRP J. Manuf. Sci. Technol. Vol. 29, pp. 36–52. – https://doi.org/10.1016/j.cirpj.2020.02.002. (In Eng.).
  18. Kritzinger, W., et al. (2018) Digital Twin in manufacturing: A categorical literature review and classification. IFAC-PapersOnLine. Vol. 51, No. 11, pp. 1016–1022. – https://doi.org/10.1016/j.ifacol.2018.08.474. (In Eng.).
  19. Litster, J., Bogle, I. D. L. (2019) Smart Process Manufacturing for Formulated Products. Engineering, Vol. 5, No. 6, pp. 1003–1009. – https://doi.org/10.1016/j.eng.2019.02.014. (In Eng.).
  20. Narayana, S. A., Pati, R. K., Vrat, P. (2014). Managerial research on the pharmaceutical supply chain – A critical review and some insights for future directions. Journal of Purchasing and Supply Management. Vol. 20. No. 1, pp. 18– 40. – https://doi.org/10.1016/j.pursup.2013.09.001. (In Eng.).
  21. Stegemann, S. (2016) The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution. Eur J Pharm Sci. Vol. 90, pp. 8–13. – https://doi.org/10.1016/j.ejps.2015.11.003. (In Eng.).
  22. Steinwandter, V., Borchert, D., Herwig, C. (2019) Data science tools and applications on the way to Pharma 4.0. Drug Discov. Today, Vol. 24, No. 9, pp. 1795–1805. – https://doi.org/10.1016/j.drudis.2019.06.005. (In Eng.).
  23. Tao, F., et al. (2018) Digital twin-driven product design, manufacturing and service with big data. Int. J. Adv. Manuf. Technol. Vol. 94, No. 4, pp. 3563–3576. – https://doi.org/10.1007/s00170-017-0233-1. (In Eng.).